Debut Plus

₹201.5

▼ -7.7 -3.68%

As of 09 Sept 2026 · delayed

NSE Listed

Chandan Healthcare Ltd. (CHANDAN)

Volume: 28,000Avg Vol 1W: 22,560Avg Vol 1M: 36,92052W Range:₹185.4₹358
NSE BSE www.chandandiagnostic.com AI Report
Key Ratios
Checked 6h ago
Market Cap₹512 Cr
Current Price₹201.5
Previous Close₹209.2
High / Low (52w)₹358 / ₹185.4
Volume28,000
Avg Vol (1W)22,560
Avg Vol (1M)36,920
Stock P/E19.48
Book Value₹69.48
Dividend Yield0%
ROE11.34%
ROA9.03%
Revenue (TTM)₹232 Cr
Revenue Growth30.3%
Profit Margin8.55%
Total Debt₹22 Cr
Shares Outstanding2 Cr
Face Value₹10
EPS (TTM)₹10.74
P/B3.01
Debt / Equity0.51
50 DMA₹235.08
200 DMA₹257.11
Day change-3.68%
Price Chart
₹201.5▼ 11.43% · 1Y
₹350₹2027.9L
2025-09-10
2026-09-09

20-day avg volume: 37K shares

Pros
  • Company is almost debt-free.
  • Net profit is growing year over year.
Cons
  • Revenue fell 24% YoY.
Quarterly Results
MetricDec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹55 Cr₹63 Cr₹68 Cr₹68 Cr₹65 Cr₹76 Cr₹81 Cr
EBITDA₹8 Cr₹10 Cr₹11 Cr₹13 Cr₹10 Cr₹10 Cr₹17 Cr
Net Profit₹4 Cr₹6 Cr₹6 Cr₹8 Cr₹5 Cr₹5 Cr₹8 Cr
EPS———————
Profit & Loss (Annual)
MetricDec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹30 Cr₹232 Cr₹37 Cr₹36 Cr₹38 Cr₹36 Cr₹45 Cr₹49 Cr
EBITDA₹6 Cr₹37 Cr₹10 Cr₹9 Cr₹11 Cr₹8 Cr₹11 Cr₹14 Cr
Net Profit₹4 Cr₹22 Cr₹6 Cr₹5 Cr₹7 Cr₹4 Cr₹7 Cr₹7 Cr
EPS—10.78——————
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹59 Cr₹65 Cr₹82 Cr₹98 Cr₹118 Cr₹211 Cr
Total Liabilities₹35 Cr₹41 Cr₹55 Cr₹68 Cr₹74 Cr₹84 Cr
Equity₹24 Cr₹24 Cr₹26 Cr₹30 Cr₹44 Cr₹126 Cr
Total Debt₹7 Cr—————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹-6 Cr₹6 Cr₹6 Cr₹6 Cr₹-21 Cr
Investing₹7 Cr₹-11 Cr₹-6 Cr₹-15 Cr₹-36 Cr
Financing₹-1 Cr₹3 Cr₹2 Cr₹16 Cr₹67 Cr
Free Cash Flow₹-6 Cr₹6 Cr₹6 Cr₹6 Cr₹-20 Cr
Shareholding
Promoter 49.61% Institutions 5.1% Public 45.29%
Efficiency & Working Capital
ROCE20.8%
Interest Coverage8
Dividend Payout—
Debtor Days74 d
Inventory Days50 d
Payable Days41 d
Cash Conversion Cycle83 d
Working Capital Days124 d
Shareholding Details

As of 2026-06-30

Promoter49.6%
FII0%
DII5.1%
Institutions5.1%
Public45.3%
Promoter Pledge0%
No. of Shareholders1,591
Shareholding Pattern

Quarterly — figures in %. Latest 7 quarters.

PeriodSept 2024Feb 2025Mar 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters69.9%49.2%49.4%49.5%49.5%49.5%49.6%
FIIs0%6.5%3.9%1.1%0%0%0%
DIIs0%0%0%0%4.8%5%5.1%
Public30.1%44.3%46.7%49.4%45.8%45.4%45.3%
Promoter Pledge0%0%0%0%0%0%0%
No. of Shareholders593,0998971,3071,4641,6241,591
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Amaranita Holdings (india) Private LimitedShareholding of Promoter and Promoter Group17%41,57,664
Amar SinghShareholding of Promoter and Promoter Group9.6%23,49,460
Vinay LambaShareholding of Promoter and Promoter Group6.5%15,84,800
Vijay SinghShareholding of Promoter and Promoter Group3.7%8,99,400
Shaleen SolankiShareholding of Promoter and Promoter Group3.7%9,00,000
Negen Undiscovered Value FundPublic Shareholding3.2%7,73,600
Vikas LambaShareholding of Promoter and Promoter Group1.8%4,50,000
Shweta LambaPublic Shareholding1.7%4,19,400
Anant Wealth ConsultantsPublic Shareholding1.6%3,97,600
Hari Shanker DixitPublic Shareholding1.4%3,50,000
Shalu AggarwalPublic Shareholding1.4%3,48,000
Amit SrivastavaPublic Shareholding1.4%3,42,240
Amita SinghPublic Shareholding1.4%3,40,000
Sandeep Kumar SaraswatPublic Shareholding1.3%3,15,200
Vivek DixitPublic Shareholding1.2%3,00,000
Alok SinghShareholding of Promoter and Promoter Group1.2%3,00,000
Bimla SinghShareholding of Promoter and Promoter Group1.2%3,00,380
Rajeev LochanPublic Shareholding1.2%2,90,400
Vikalp DixitPublic Shareholding1.1%2,78,200
Keya Vimal SalotPublic Shareholding1.1%2,73,600
Dharmendra Singh MalikShareholding of Promoter and Promoter Group1%2,41,500
Nisha LambaShareholding of Promoter and Promoter Group0.9%2,23,300
Asmita SinghShareholding of Promoter and Promoter Group0.7%1,69,200
Vishal LambaShareholding of Promoter and Promoter Group0.6%1,51,180
Anant SinghShareholding of Promoter and Promoter Group0.5%1,13,000
Board of Directors
NameDesignationYear
AMAR SINGHChairman & Managing Director2025
Vinay LambaNon Executive Director2025
ASMITA SINGHManaging Director2025
Amit GuptaIndependent Non Exe. Director2025
Vinod JainIndependent Director2025
Brahma Nand BhartiyaIndependent Non Exe. Director2025
HARI SHANKER DIXITNon Executive Director2025
Rajeev NainCFO / Company Secretary / Compliance Officer2025
Segments — Product
SegmentRevenueShare
State-of-the-art laboratories provi₹0 Cr—
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10252424
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-14Board Meetings—
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2024000-097
202400001313
2024000112
Company Information
Incorporated2003
ChairmanAMAR SINGH
AuditorMSNT & Associates LLP
Investor Email[email protected]
🌐 www.chandandiagnostic.com ↗

📍 Biotech Park Sector G, Jankipuram Kursi Road, Lucknow, Uttar Pradesh, 226021

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

CG Power & Industrial Solutions Ltd.Creative Graphics Solutions India Ltd.C G V A K Software & Ex LimitedChalet Hotels LimitedChambal Fertilisers & Chemicals Ltd.Chamunda Electrical Ltd.Chavda Infra LimitedChembond Material Technologies Ltd.Chembond ChemicalsChemcon Speciality Chemicals Ltd.Chemcrux Enterprises Ltd.Chemfab AlkalisAll “C” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search